Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 24.58 USD 2.12% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Nurix Therapeutics Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nurix Therapeutics Inc
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Nurix Therapeutics Inc
NASDAQ:NRIX
Accrued Liabilities
$32.5m
CAGR 3-Years
58%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
$5.2B
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$13.7B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
$2.9B
CAGR 3-Years
26%
CAGR 5-Years
22%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.4B
CAGR 3-Years
5%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Nurix Therapeutics Inc's Accrued Liabilities?
Accrued Liabilities
32.5m USD

Based on the financial report for Nov 30, 2023, Nurix Therapeutics Inc's Accrued Liabilities amounts to 32.5m USD.

What is Nurix Therapeutics Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
60%

Over the last year, the Accrued Liabilities growth was 16%. The average annual Accrued Liabilities growth rates for Nurix Therapeutics Inc have been 58% over the past three years , 60% over the past five years .

Back to Top